Journal
SCHIZOPHRENIA RESEARCH
Volume 93, Issue 1-3, Pages 261-265Publisher
ELSEVIER
DOI: 10.1016/j.schres.2007.03.022
Keywords
C-reactive protein; immune response; inflammatory marker; schizophrenia; cognitive
Categories
Ask authors/readers for more resources
Objectives: We investigated the association between serum levels of C-reactive protein (CRP), a marker of inflammation, and the severity of psychopathology and cognitive impairment in schizophrenia. Methods: We measured the levels of CRP in N=413 individuals with schizophrenia. Symptom severity was evaluated with the Positive and Negative Syndrome Scale (PANSS) and cognitive functioning with the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). Results: The individuals with CRP >= 5.0 mg/mu l had significantly lower RBANS cognitive scores than those with CRP < 5.0 mg/mu l (F=8.077 p <.005). However the CRP groups did not differ in the severity of positive, negative, or general PANSS symptoms (all p >.2). Conclusions: Elevated serum levels of C-reactive protein in schizophrenia are associated with the severity of cognitive impairment but not of psychiatric symptoms. The long term consequences of elevated levels of CRP require further investigation. (c) 2007 Elsevier B.V. All fights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available